HCA Healthcare (NYSE:HCA) Cut to Market Perform at Raymond James

HCA Healthcare (NYSE:HCA) was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating in a note issued to investors on Friday, MarketBeat reports.

A number of other equities research analysts also recently issued reports on the company. TD Cowen lowered their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. KeyCorp lowered their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. UBS Group increased their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Finally, Oppenheimer raised their price target on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Six equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $324.93 on Friday. HCA Healthcare has a one year low of $245.84 and a one year high of $417.14. The business has a fifty day moving average price of $379.40 and a 200-day moving average price of $358.35. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market capitalization of $82.30 billion, a P/E ratio of 14.59, a PEG ratio of 1.28 and a beta of 1.68.

Insider Buying and Selling

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 over the last ninety days. 1.60% of the stock is owned by insiders.

Institutional Trading of HCA Healthcare

Several large investors have recently bought and sold shares of the company. Unigestion Holding SA boosted its position in HCA Healthcare by 72.2% during the 3rd quarter. Unigestion Holding SA now owns 1,595 shares of the company’s stock valued at $648,000 after acquiring an additional 669 shares in the last quarter. TD Private Client Wealth LLC raised its holdings in HCA Healthcare by 3.8% in the 3rd quarter. TD Private Client Wealth LLC now owns 4,585 shares of the company’s stock worth $1,863,000 after acquiring an additional 167 shares during the last quarter. Sunbelt Securities Inc. raised its holdings in HCA Healthcare by 14.0% in the 3rd quarter. Sunbelt Securities Inc. now owns 2,377 shares of the company’s stock worth $966,000 after acquiring an additional 292 shares during the last quarter. Chiron Investment Management LLC purchased a new position in HCA Healthcare in the 3rd quarter worth approximately $3,548,000. Finally, Coldstream Capital Management Inc. raised its stake in HCA Healthcare by 11.5% during the 3rd quarter. Coldstream Capital Management Inc. now owns 3,427 shares of the company’s stock valued at $1,374,000 after buying an additional 353 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.